Immortalized Human Oral Keratinocytes

Cat.No.: CSC-I9230L

Species: homo sapiens

Source: Human Oral Mucosa

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
  • Documents
Cat.No.
CSC-I9230L
Description
Immortalized Human Oral Keratinocytes-hTERT from Creative Bioarray were developed from human tissues were transduced with a lentiviral expression vector containing the hTERT gene. The cell line was continuously cultured for more than 50 population doublings without showing signs of growth retardation or replicative senescence.
Species
homo sapiens
Source
Human Oral Mucosa
Recommended Medium
SuperCult® Immortalized Human Oral Keratinocyte Medium (Cat No.: CM-I9230L)
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Immortalization Method
Human telomerase reverse transcriptase (hTERT) and SV40 large T antigen
Application
For Research Use Only
Growth Properties
Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2.
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CSC-7745W Human Oral Keratinocytes (HOK)
CIK-HT013 HT® Lenti-hTERT Immortalization Kit
CIK-HT003 HT® Lenti-SV40T Immortalization Kit
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized Human Oral Keratinocytes (IHOKs) represent a pivotal in vitro model system engineered to overcome the significant limitations of primary oral keratinocytes. Primary cells, typically isolated from gingival, buccal, or palatal mucosa, have a finite replicative lifespan, undergo rapid terminal differentiation in culture, and exhibit substantial donor-to-donor variability due to age, health status, and anatomical site. These constraints hinder reproducible, long-term mechanistic studies. Immortalization, commonly achieved through the introduction of viral oncogenes (e.g., HPV16 E6/E7 or SV40 Large T antigen) or the catalytic subunit of human telomerase (hTERT), confers an extended, stable proliferative capacity while aiming to preserve the essential phenotypic and functional characteristics of their tissue of origin.

The defining advantage of well-validated IHOK lines is their provision of a genetically uniform, sustainable, and experimentally tractable human epithelial system that closely mimics the in vivo oral mucosal lining.

Cytotoxicity and Antifungal Effects of Combined Dexamethasone and Miconazole on Human Oral Keratinocytes and Gingival Fibroblasts

Oral lichen planus (OLP), a prevalent immune-mediated inflammatory condition, requires effective therapies. Topical corticosteroids, such as dexamethasone (Dex), are widely used for OLP treatment. However, they can predispose patients to secondary candidiasis, necessitating adjunctive therapy with antifungal agents like miconazole (Mz). Little is known about the cellular dynamics and toxicity of the combined use of dexamethasone and miconazole. This study examined the effect of dexamethasone on the antifungal activity of miconazole against Candida albicans and the effect of miconazole on the immunosuppressive activity of dexamethasone on human T cells. The cytotoxicity of dexamethasone alone and dexamethasone combined with miconazole on human oral keratinocytes (NOKs) and gingival fibroblasts (GFs) was also determined using both in vitro monolayer and Transwell co-culture models.

Dexamethasone did not affect miconazole's antifungal efficacy, and a single exposure of miconazole inhibited over 99% of C. albicans growth. In monolayer cultures, 0.05% dexamethasone was non-toxic to keratinocytes and fibroblasts, while miconazole exhibited dose-dependent cytotoxicity at high concentrations. Transwell co-culture models confirmed this dose-dependent cytotoxicity, with higher miconazole concentrations causing increased apoptosis. Dexamethasone significantly reduced T cell viability, activation, and proliferation, unaffected by miconazole co-treatment. In conclusion, when used in combination at optimal concentrations, miconazole's antifungal activity and dexamethasone's anti-T-cell proliferation activity are retained without cytotoxicity to human oral cells.

Effect of drug treatment (Dex and/or Mz) on the viability of GFs and NOKs.

Fig. 1. Effect of Dex and Mz on the viability of GFs and NOKs (Muangsanit, Papon, et al., 2025).

Effect of drug treatment (Dex and Mz) on the keratinocyte-fibroblast Transwell co-culture model.

Fig. 2. Effect of Dex and Mz on the viability of oral keratinocyte-fibroblast Transwell co-culture model (Muangsanit, Papon, et al., 2025).
What are Immortalized Human Oral Keratinocytes-hTERT?

Immortalized Human Oral Keratinocytes-hTERT are oral keratinocyte cells derived from human sources that have been modified with the human telomerase reverse transcriptase (hTERT) gene. This modification allows the cells to go beyond 20 passages while retaining essential characteristics of primary oral keratinocytes.

What research applications are Immortalized Human Oral Keratinocytes-hTERT suitable for?

Immortalized Human Oral Keratinocytes-hTERT are suitable for a wide range of applications, including:
Oral cancer research and carcinogenesis studies.
Oral biology and tissue engineering.
Wound healing and regenerative medicine.
Drug testing and toxicity assays relevant to oral tissues.
Studies on cell differentiation, signaling, and interactions in the oral epithelium.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products